Pensions & Investments Logo
ETF Exchange > XDNA ETF

XDNA - ETF Fact Sheet

iShares Genomics Immunology and Healthcare Index ETF - CAD

Fund Identification

Ticker

XDNA

ISIN

CA46437W1059

Main Metrics

Price

$41.65

Expense Ratio

0.44%

AuM

$6.25M

Tracking Difference

-0.76%

Ratings

Trackinsight rating

ESG Consensus®

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise

Official Investment Strategy

The ETF has been designed to provide investors with exposure to the performance of an index, selected at the discretion of BlackRock, that is composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. The current index for the ETF is the NYSE FactSet Global Genomics and Immuno Biopharma Index.

XDNA's historical prices, performance, and flows

-5.0-4.0-3.0-2.0-1.00.0%
1m returns
-1.21%
1m flows
$0M
* Net total returns
All data as of 6 April 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all XDNA data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

XDNA's characteristics

Manager

Manager statistics

1733 funds, $5,675.55Bn in AUM

Benchmark

NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing

Meets ESG criteria

No
XDNA's exposure

Countries

USA
63.05%
France
8.82%
Other
28.13%

Sectors

Health Care
94.70%

Top 5 holdings

MODERNA INC
6.58%
Other
5.29%
ARCELLX
4.91%
IPSEN PROMESSES
4.67%
TAKEDA PHARMACEUTICAL
4.48%
Total holdings
42
Total weight of top 5
25.92%
0.0%